Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends
March 03, 2023 00:27 ET
|
Novotech
SINGAPORE, March 03, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is convening an expert panel webinar with Endpoints...
Novotech Acquires US-based Drug Development Consulting Firm, CBR International - Expands Drug Development and FDA Regulatory Expertise
January 09, 2023 11:34 ET
|
Novotech
SINGAPORE, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR International, a global product development, clinical...
Novotech Acquires European CRO – Strengthens Global Operations
January 09, 2023 11:33 ET
|
Novotech
SINGAPORE, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important...
Data Shows 50% of New Trials Have Sites in Asia Pacific
December 14, 2022 20:06 ET
|
Novotech
SINGAPORE, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication by GlobalData and Novotech found almost 50% of...
Clinical Research Opportunities in China and the Path to USFDA Approval – Whitepaper
October 30, 2022 18:10 ET
|
Novotech
SYDNEY, Australia, Oct. 30, 2022 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific biotech specialist CRO, and GlobalData have published the latest China biotech landscape analysis with expert...